Home › NDC Lookup › RxCUI directory › RxCUI 847734

Artemether 20 MG / lumefantrine 120 MG Oral Tablet [Coartem] — RxCUI 847734

RxNorm drug concept · Semantic branded drug
RxCUI 847734 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI847734
Official nameArtemether 20 MG / lumefantrine 120 MG Oral Tablet [Coartem]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asCoartem 20 MG / 120 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Artemether and Lumefantrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Coartem is a treatment, not a prevention. It's prescribed to treat an active malaria infection caused by the Plasmodium falciparum parasite — including strains that no longer respo...
  • What is Coartem actually for — can it prevent malaria if I'm traveling?
  • Eating with Coartem is genuinely important — not just a suggestion. Food, especially something with a little fat in it, increases how much lumefantrine your body absorbs by up to 1...
  • Why does it matter so much whether I eat when I take this medicine?
📖 Read our full Artemether and Lumefantrine guide →

🕸️ Concept Web — How Artemether 20 MG / lumefantrine 120 MG Oral Tabl... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Artemether 20 MG / lumefantrine 120 MG Oral Tablet [Coartem] RxCUI 847734

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Artemether 18343
    • Lumefantrine 847728
    • Artemether / lumefantrine 282448
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Coartem 718834
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Artemether / lumefantrine Oral Tablet 847730
    • Artemether / lumefantrine Oral Product 1158266
    • Artemether / lumefantrine Pill 1158267
    • Artemether / lumefantrine Oral Tablet [Coartem] 847733
    • Coartem Oral Product 1174426
    • Coartem Pill 1174427
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Artemether 20 MG / lumefantrine 120 MG Oral Tablet SCD · 847731
  • Artemether 20 MG SCDC · 393336
  • Lumefantrine 120 MG SCDC · 847729
  • Artemether / lumefantrine Oral Tablet SCDF · 847730
  • Artemether / lumefantrine Oral Product SCDG · 1158266
  • Artemether / lumefantrine Pill SCDG · 1158267

Brand-Name Concepts

  • Artemether 20 MG / lumefantrine 120 MG [Coartem] SBDC · 847732
  • Artemether / lumefantrine Oral Tablet [Coartem] SBDF · 847733
  • Coartem Oral Product SBDG · 1174426
  • Coartem Pill SBDG · 1174427
  • Coartem BN · 718834

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 847734 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00078-0568-45 24 TABLET in 1 BOTTLE (0078-0568-45) COARTEM Novartis Pharmaceuticals Corporation 2009-04-07
Observed labelers: Novartis Pharmaceuticals Corporation (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$5.3628
Range $5.3628–$5.3628 · middle 50% $5.3628–$5.3628 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.